Scetamina (Spravato): new intranasal drug for depression

Etesamine is an appropriate substance for the treatment of depression resistant to other treatments, in adults, which should be used in combination with another oral antidepressant. This drug is not yet marketed in Brazil, but has already been approved by the FDA to be marketed in the United States, under the trade name Spravato, for […]

Scetamina (Spravato): new intranasal drug for depression Read More »